Home Overview Press Room Blog Publications For Students about us
Search

Japan to Start Stem-Cell Study on Humans

by David CyranoskiNature
July 30th, 2013

Dr. Masayo Takahashi
Dr. Masayo Takahashi

On 1 August, researchers at the RIKEN Center for Developmental Biology in Kobe, Japan, will start recruiting patients for the world’s first clinical study using induced pluripotent stem (iPS) cells.

RIKEN’s endorsement, officially announced today, was the final stage in a long series of regulatory steps that included approval from the health ministry.

Ophthalmologist Masayo Takahashi will be using sheets of retinal pigment epithelium cells, derived from iPS cells, to try to halt the progression of age-related macular degeneration. In the wet-type AMD targeted by Takahashi, abnormal vascularization invades and destabilizes the epithelium, which supports the photoreceptors, and causes loss of vision.

The iPS cells will be genetically identical to each patient’s cells and thus, it is hoped, will avoid problems with immune rejection that hampered past attempts to use fetal-derived cells.

Each of six patients will receive a graft in a single affected eye. The process will be time consuming: deriving the iPS cells and preparing the sheets will take ten months. Progress of the treatments, which will be staggered by eight weeks per patient, will be tracked for three years.

The clinical study is different from a clinical trial and will not, even if successful, open the door for widespread clinical use. But researchers hope it will show enough efficacy to encourage formal clinical trials.



This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of biotechnology and public policy issues. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.copyright.gov/title17/92chap1.html#107. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760